Future working capital through the exercise of stock acquisition rights
First written in FY2017-Q2. 2 of 4 entries say "Dropped", first in FY2017. Latest entry: FY2018.
0 other companies' latest entry also says "Dropped".
- FY2018DroppedAnnual report
「Proceeds from the issuance of stock acquisition rights 2」
The annual report states proceeds of ¥2 million from the issuance of stock acquisition rights, but does not repeat the explanation that net proceeds from exercise are scheduled to be allocated to working capital. - FY2018-Q1RestatedAnnual report
「Accordingly, the net proceeds are scheduled to be allocated to working capital, but the specific amount will be determined based on the circumstances at the time payment is made upon exercise.」
The explanation that net proceeds from the exercise of stock acquisition rights are scheduled to be allocated to working capital has again been included as a material subsequent event. - FY2017DroppedAnnual report
「Proceeds from the issuance of stock acquisition rights 5」
The annual report states proceeds of ¥5 million from the issuance of stock acquisition rights, but does not repeat the explanation that proceeds from exercise are scheduled to be allocated to future working capital. - FY2017-Q2First statedAnnual report
「These stock acquisition rights are being issued to further strengthen the sense of unity and cohesion among the Company's officers and employees and to improve their motivation and morale as the Company seeks to expand its business performance and increase corporate value. They are not being issued for the purpose of raising funds. Accordingly, the net proceeds are scheduled to be allocated to working capital, but the specific amount will be determined based on the circumstances at the time payment is made upon exercise.」
The Company issued the Fourth and Fifth Series of Stock Acquisition Rights through a third-party allotment. The potential number of shares was 3,000,000, the exercise price was ¥720 per share, and estimated net proceeds were ¥2,153,700,000. The primary purpose of the issuance was to provide incentives to officers and employees, and the Company explained that proceeds from exercise were scheduled to be allocated to future working capital.